Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
Biomarker and diagnostic research for thrombocytopenic purpura has been reported in the published literature.
42 clinical trials registered, 22 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 3 PHASE3, 5 PHASE2, 4 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07353099](https://clinicaltrials.gov/study/NCT07353099) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:56 PM UTC
A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma |
— |
Takeda |
RECRUITING |
[NCT04890041](https://clinicaltrials.gov/study/NCT04890041) | TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years | NA | Institute of Hematology & Blood Diseases Hospital, China | RECRUITING |
[NCT01257269](https://clinicaltrials.gov/study/NCT01257269) | Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) | — | Insel Gruppe AG, University Hospital Bern | RECRUITING |
[NCT06757257](https://clinicaltrials.gov/study/NCT06757257) | Special Drug Use-results Survey for Long-term Use (Fostamatinib) | — | Kissei Pharmaceutical Co., Ltd. | RECRUITING |
[NCT06831058](https://clinicaltrials.gov/study/NCT06831058) | A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) | PHASE2 | University of Minnesota | RECRUITING |
303 publications have been identified in PubMed for thrombocytopenic purpura. Research spans Review / Meta-Analysis (31%), Case Report / Case Series (24%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 94 | 31% |
Patient case studies | 73 | 24% |
Disease patterns and progression | 39 | 13% |
Laboratory research | 37 | 12% |
Clinical study results | 28 | 9% |
Testing and diagnosis research | 15 | 5% |
New treatment approaches | 12 | 4% |
Other research | 5 | 2% |
Wu M (2026). [PMID: 42077001](https://pubmed.ncbi.nlm.nih.gov/42077001/). *Blood Coagul Fibrinolysis*. [Case Report / Case Series]
Halkidis K (2026). [PMID: 41917369](https://pubmed.ncbi.nlm.nih.gov/41917369/). *Methods Mol Biol*. [Diagnostic / Biomarker]
Unknown (2026). [PMID: 41702381](https://pubmed.ncbi.nlm.nih.gov/41702381/). *Hamostaseologie*. [Epidemiology / Natural History]
Han J (2026). [PMID: 41907348](https://pubmed.ncbi.nlm.nih.gov/41907348/). *Obstet Med*. [Case Report / Case Series]
Kühne L (2026). [PMID: 41159657](https://pubmed.ncbi.nlm.nih.gov/41159657/). *American journal of hematology*. [Case Report / Case Series]
Yassin M (2026). [PMID: 41478741](https://pubmed.ncbi.nlm.nih.gov/41478741/). *Blood Rev*. [Review / Meta-Analysis]
Schimmer R (2026). [PMID: 42078821](https://pubmed.ncbi.nlm.nih.gov/42078821/). *Res Pract Thromb Haemost*. [Clinical Trial Publication]
Story CM (2026). [PMID: 42109864](https://pubmed.ncbi.nlm.nih.gov/42109864/). *Res Pract Thromb Haemost*. [Epidemiology / Natural History]
Zhang N (2026). [PMID: 41376564](https://pubmed.ncbi.nlm.nih.gov/41376564/). *Haematologica*. [Case Report / Case Series]
Huang K (2026). [PMID: 41036697](https://pubmed.ncbi.nlm.nih.gov/41036697/). *Expert Rev Hematol*. [Review / Meta-Analysis]